This new article publication from Acta Pharmaceutica Sinica B, discusses therapeutic drug monitoring of biologics in inflammatory bowel disease.

Evaluating quality of life (QOL) in patients with idiopathic pulmonary fibrosis (IPF) goes beyond lung function numbers. It also shows how treatments affect daily well-being and guides funding, ...

Guidelines emphasize single-pill combinations and deprescribing strategies to combat polypharmacy and hyperpolypharmacy in ...

Doug Wolfberg’s message is clear and deliberately uncomfortable: in EMS, the standard of care is never declared in advance, ...

Introduction The transition from clinical practice to an academic role presents a multifaceted challenge for anaesthesia master’s students in Iran, as it demands not only clinical expertise but also ...

Hormone replacement therapy applied via the skin is the best way of protecting bone density in women whose periods have stopped due to anorexia or intense exercise, according to new research from ...

Professor Chan Kwon Jung, director of Smart Hospital and Biobank at Seoul St.Mary's Hospital, underscores the need for national support in implementing AI systems in hospitals.

Over the past 20 years, courts have clarified that clinical practice guidelines are helpful but not definitive standards of care. They can be used by experts as part of their reasoning but are not ...

Van de Garde teaches pharmacotherapy to Utrecht students and conducts research into the use and effectiveness of medicines in routine clinical practice.

Abstract: Anemia is a disease that is always present from early stages; children are the most prone to contracting it from birth if it's not diagnosed, which can lead to more severe illnesses.

AI is reshaping clinical practice in retinal imaging and workflow optimization, according to Priv.-Doz. Dr. med. Jan H.

In a significant shift for the treatment landscape of essential thrombocythemia (ET), the US National Comprehensive Cancer Network (NCCN) has designated ropeginterferon alfa-2b-njft (Besremi) as a ...